- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07196813
- Original Trial
The Association Between the Extubation Process and Delirium in the Intensive Care Unit
Evaluation Of The Relationship Between Weaning Process And Delirium
There are limited studies in the literature investigating the relationship between delirium and the pre- and post-extubation periods in patients planned for extubation. Determining the impact of existing delirium during the extubation process or the possible causes of delirium occurring in this period may contribute to early recognition, prevention, or treatment of delirium. In our study, we screened patients scheduled for extubation in the intensive care unit using the Confusion Assessment Method for the ICU (CAM-ICU) before extubation and during the 48-hour post-extubation period to investigate the type of delirium, its relationship with sedation, and possible triggering and risk factors.
Methods: The study was conducted with 38 patients over 18 years old who had been on mechanical ventilation (MV) for at least 24 hours and had Richmond Agitation and Sedation Scale (RASS) scores between +4 and -3. CAM-ICU was applied to patients before extubation, and then the patients were weaned from mechanical ventilation. Age, sex, APACHE-II, SOFA, mCCI scores, length of stay, and duration of intubation were compared between CAM-ICU negative and positive patients before extubation, and the relationship with sedation type was evaluated. CAM-ICU was also applied at 24 and 48 hours after extubation, and the results were compared with arterial blood gas parameters including PaO2/FiO2, PCO2, and lactate levels.
Study Overview
Status
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Eskişehir, Turkey (Türkiye)
- Eskişehir Osmangazi University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Inclusion criteria were patients aged over 18 years, followed under MV for at least 24 hours, with a Richmond Agitation and Sedation Scale (RASS) score between +4 and -3, and for whom an extubation decision had been made
Exclusion Criteria:
- Exclusion criteria were patients with RASS scores of -4 or -5, patients with a history of neurocognitive disorders (dementia, Alzheimer's disease), and patients whose relatives did not provide consent
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The association between delirium and the 24-hour period before extubation and the 48-hour period after extubation in 38 patients for whom extubation was indicated.
Time Frame: Patient assessments were conducted during the period immediately before extubation and within the 48-hour period following extubation
|
The study was carried out in patients who were followed under MV and in whom a decision for extubation was made by the attending physician.
The sample size was determined as 38 patients.
Delirium screening was performed using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) during the period immediately before extubation and within the 48-hour period after extubation.
In sedated patients, the sedative agent was recorded, and sedation was gradually reduced and discontinued 4-6 hours before each assessment.
Immediately before extubation, the RASS was applied to assess the level of sedation and agitation.
Patients with RASS scores between +4 and -3 were assessed using the CAM-ICU.
At 24 and 48 hours after extubation, RASS was applied first, followed by CAM-ICU.
Patients with a positive CAM-ICU result were considered to have delirium.
The delirium subtype was determined according to the RASS score
|
Patient assessments were conducted during the period immediately before extubation and within the 48-hour period following extubation
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- E-80558721-050.99-328825
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mechanical Ventilation Complication
-
Assiut UniversityRecruitingMechanical Ventilation Complication | Anesthesia ComplicationEgypt
-
Jose Ivan Rodriguez de Molina SerranoCompletedMechanical Ventilation Complication | Mechanical Power | Driving Pressure | Lung Protective VentilationMexico
-
Università degli Studi di FerraraArcispedale S. Anna, FerraraRecruitingEffect of Goal-directed Analgesia and Sedation Using EEG Derived QCON/qNOX in ICU Patients (SED_ICU)Mechanical Ventilation Complication | Sedation ComplicationItaly
-
Johns Hopkins UniversityCompletedMechanical Ventilation ComplicationUnited States
-
Albert Einstein Healthcare NetworkTerminatedMechanical Ventilation ComplicationUnited States
-
Sherin Hassan Mohammed MehaniCompletedMechanical Ventilation ComplicationEgypt
-
Cairo UniversityCompletedMechanical Ventilation ComplicationEgypt
-
Shaare Zedek Medical CenterUnknownMechanical Ventilation ComplicationIsrael
-
Seoul National University HospitalCompletedMechanical Ventilation ComplicationKorea, Republic of
-
University of Campinas, BrazilUnknownMechanical Ventilation ComplicationBrazil